Why read
In our industry, the landscape is dominated by mechanical innovations, but some of the biggest breakthroughs are non- mechanical.
This UK-based pioneer, gearing up for a US launch, offers Orthotype—a groundbreaking blood test using machine learning and genetic typing to preempt metal sensitivities that plague up to 20% of patients with unexplained post-surgery pain.
Discover why ExplantLab isn't just another startup but the key to personalized, litigation-proof orthopedics, slashing revision rates and ushering in an era of immunological precision that every surgeon, investor, and patient advocate needs to know about.
We’ve spent decades obsessing over mechanics. We talk about bearing surfaces, fixation, robotic precision, and wear rates. But even with the most perfectly placed implant, there is a ghost in the machine that the industry has largely ignored: The Patient’s Biology.
The BoneChat members recently sat down with Imanol Echevarria CEO at ExplantLab. If you aren’t familiar with them yet, pay attention. Based in the UK, ExplantLab is doing the deep forensic and biological work that the orthopedic industry has needed for twenty years.
As they pre...
